Prolonged protective effect of propranolol on hypoxic heart muscle.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D003327:Coronary Disease / Q000378:metabolism / Q000517:prevention & control*; D003402:Creatine Kinase / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D000860:Hypoxia / Q000378:metabolism*; D007279:Injections, Subcutaneous; D008297:Male; D008929:Mitochondria, Heart / Q000378:metabolism; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D010101:Oxygen Consumption; D010725:Phosphocreatine / Q000378:metabolism; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits; D013997:Time Factors
D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D006003:Glycogen; D011433:Propranolol; D003402:Creatine Kinase